CASSAVA SCIENCES INC
(NASDAQ: SAVA)

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

21.725

+0.985 (+4.75%)
Range - - -   (-%)
Open -
Previous Close 20.740
Bid Price 25.100
Bid Volume 11
Ask Price 25.370
Ask Volume 11
Volume 910,023
Value -
Remark
Delayed prices. Updated at 26 Apr 2024 03:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis